The main aim is to study on prescribing patterns of anti-diabetic drugs for patients with type- II diabetes mellitus. Out of 457 patients screened, 426patients were enrolled according to inclusion and exclusion criteria. Among them 62.44% were males and 37.55% were females. The study found to be a higher incidence of diabetes among elderly patients, with a high incidence in the age group between 41-60 years (50.70%) and followed by 61‑80 years (19.24%). The study resolved that most of the patients were suffering from diabetes for 5 to 10 years, 221 (73.94%) of duration years followed by 1 to 5 years, 94 (22.06%). A total of 1565 drugs were prescribed in the overall study period. 68.62% were diabetic drugs, 13.41% hypertensive drugs, 07.85% NSAIDs, 07.66% asthmatic drugs, 03.57% antidepressants, and 04.40% supplements of drugs. The study resolved that drugs were prescribed as monotherapy was 49.76%, two drug therapy were 36.61%, three-drug therapy were 08.45% and four-drug therapy was 05.16%. In this study, 426 anti-diabetic drugs prescribed, among that, the physician's most well-liked single-drug therapy more than multiple drug therapy and also the most often prescribed category was Biguanides category of anti-diabetic agents. Among Biguanides, Metformin was the foremost often utilized anti-diabetic drugs. The foremost prevalent combination of the drug was a two-drug therapy of Biguanides +sulfonylureas, among these combinations, Metformin + Glimipride was the foremost often utilized anti-diabetic drugs. Followed by 3 drug therapy were Biguanides +sulfonyl ureas+ thiazolidinedione and 4 drug therapies were Biguanides + sulfonylureas + DPP 4 inhibitors + thiazolidinedione.Pharmacists can contribute drastically to promote the rational use of medicines, even in resource-limited settings. This, of course, requires strong collaboration between different institutions and commitments of the pharmacists to the cause. Pharmacist medication review, patient counseling and telephone follow-up can limit the Adverse Drug Reactions. Medication discrepancies before and after discharge were common targets of intervention.
No takes yet. Share an insight, caveat, or question.
Iram et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: